Advertisement

Banner EBD Group BIO Europe 2014 BEU Frankfurt November 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6249 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 61 62 63  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Formycon–SEVERAL: investment, 201310–201312 capital increase €9.4m 1.257m new common shares €7.5/share to existent shareholders 2013-10-28
Genetrix (ES)–SEVERAL: investment, 201310 rights offering + private placement of Sygnis AG €2.7m with 1.02m new shares €2.65/share 2013-10-28
Hana Pharmaceuticals–Paion: remimazolam, 201310– license excl €1m upfront + €2m milestones + 10% royalties for dev + manuf + commerc in Korea 2013-10-28
Biotest–SEVERAL: credit, 201310– placing of €210m notes in different tranches to more than 70 investors 2013-10-24
Celesio–McKesson: investment, 201310– acquisition €6.1b with acqu of 50.01% shares from Haniel + cash tender offer for all remaining shares €23/share 2013-10-23
Boehringer–Beactica: drug discovery services, 201310– collab expansion €na fragment-based drug discovery services for oncology-relevant kinases 2013-10-22
Heraeus–Curetis: molecular diagnostics, 201310 collab existent co-developm + co-marketing of Unyvero i60 ITI application 2013-10-22
AstraZeneca–Evotec: kidney disease drugs, 201310– license + collab agreem €na giving AZ access to selected series of molecules to treat CKD 2013-10-21
Clovis Oncology–Qiagen: molecular companion diagnostics, 201310– collab developm of therascreen EGFR RGQ PCR Kit for CO-1686 2013-10-21
Mérieux–MC Services: public relations, 201310 service existent for Transgene SA 2013-10-21
Austria (govt)–Biocom: publishing, 201310 supply service with regard to Vienna Life Science Report 2013/14 to LISAvienna by Biocom 2013-10-17
Boehringer–Vector Capital: drug discovery s/w, 201310– supply Certara D360 as drug discovery platform in Ridgefield + Biberach + Vienna 2013-10-17
Suzhou SJ Biomaterials–Scienion: print/spotting technology, 201310– distribution of Scienion products in China by Suzhou SJ Biomaterials Co Ltd 2013-10-17
Sygnature Discovery–Proteros: drug discovery services, 201310– collab strategic alliance to offer integrated services incl X-ray structure analysis 2013-10-17
Photonics Healthcare–Bavaria (govt): investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–High-Tech Gründerfonds: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–SEVERAL: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
CV genes-at-target project–Evotec: genomic drug target discovery, 2013– collab European ScreeningPort is partner in FP7 project 2013-10-15
CV genes-at-target project–Univ Lübeck: genomic drug target discovery, 2013– collab Univ of Lübeck is partner in FP7 project 2013-10-15
Immatics–SEVERAL: investment, 201310 financing round Series D 1st tranche €12m of €34m round Hopp + Strüngmann + Wellington Partners + MIG Funds 2013-10-15
Bayer–BioInvent: antibody library, 201310 license €na extension + broadening to n-CoDeR libraries for development of therapeutic antibodies 2013-10-14
Wilex–MC Services: public relations, 201310 service existent for Wilex AG 2013-10-10
Bayer–RWTH Aachen: bioinformatics, 201310– collab founding of Joint Research Center on Computational Biomedicine by BTS + RWTH 2013-10-09
Bayer–Sysmex: molecular companion diagnostics, 201310– collab master agreem for developm of blood-based CDx for cancer drugs by Sysmex Inostics 2013-10-09
Sartorius–PERSON: investment, 201310 existent family of the late Horst Satorius owns 50.09% bound by last will of Horst Satorius 2013-10-09
Schott–Sony: slides, 201310 collab developm + marketing of glass-plastic hybrid cell imaging slide 2013-10-07
JnJ–CureVac: vaccine technology, 201310– collab + license €na use of RNActive technology for developm of mRNA-based influenza vaccine with Crucell 2013-10-03
Merus–Akampion: public relations, 201310 service existent by Akampion 2013-10-03
Findeisen Laborbedarf–Omnilab (DE): investment, 201310 acquisition of Findeisen Laborbedarf GmbH by Omnilab-Laborzentrum GmbH & Co KG 2013-10-01
Analytik Jena–Endress+Hauser: investment, 201309– mandatory offer for remaining 52.67% of shares for €13.75/share 2013-09-27
Analytik Jena–PERSON: investment, 201309 existent founder + CEO Klaus Berka owns 9.93% 2013-09-27
Merck (DE)–Ablynx: Nanobodies, 201309– collab co-discovery + co-developm Nanobodies extension Merck Serono 2013-09-26
Panoptes Pharma–4SC: investment, 201309 4SC Discovery receives 24.9% share in Panoptics as part of license for PP-001 2013-09-26
Panoptes Pharma–4SC: PP-001, 201309– license for inflammatory eye diseases against 24.9% share in Panoptes plus milestones + royalties 2013-09-26
Indivumed–Sysmex: investment, 201309–201310 acquisition of 100% of Inostics GmbH + its subsidiary Inostics Inc by Sysmex Corp 2013-09-25
Partec–Sysmex: investment, 201309 acquisition of Partec GmbH by Sysmex Corp 2013-09-24
Myelo Therapeutics–Berlin (govt): investment, 201309 financing round Series A incl VC Fonds Technologie Berlin 2013-09-23
Myelo Therapeutics–Eckert Wagniskapital: investment, 201309 financing round Series A incl Eckert Wagniskapital und Frühphasenfinanzierung GmbH 2013-09-23
Myelo Therapeutics–JSC Valenta Pharmaceuticals: investment, 201309 financing round Series A incl JSC Valenta Pharmaceuticals 2013-09-23
Myelo Therapeutics–SEVERAL: investment, 201309 financing round Series A from VC Fonds Technologie Berlin + Eckert Wagniskapital + JSC Valenta 2013-09-23
IKFE–Columbia Healthcare Services: investment, 201309 acquisition 100% of IKFE Services GmbH which continues business of bankrupt IKFE Institut 2013-09-18
MorphoSys–SEVERAL: investment, 201309 private placement €84m with 1.5m new shares €55.76/share to institutional investors 2013-09-18
Evonik–Genedata: bioinformatics, 201309– collab expansion use of integrated Genedata offering incl Genedata Selector 2013-09-17
Microstim–SEVERAL: investment, 201309 financing round €500k MVP + HTGF + Fides Finanz-Invest 2013-09-17
Affimed–MC Services: public relations, 201309 service existent for Affimed Therapeutics AG 2013-09-16
Bruker Corp–Siscapa: SISCAPA assay technology, 201309– collab extension developm SISCAPA-MALDI workflows + installation in demo facility 2013-09-16
Rhön-Klinikum–Fresenius: investment, 201309– acquisition of 43 German hospitals for €3.07b by Fresenius Helios ANNOUNCED 2013-09-13
Evotec–Harvard Univ: drug discovery, 201309– collab €na drug discovery for ALS using iPS cells with HSCI 2013-09-12
Bayer–MIT: personalised cancer drugs, 201309– collab 5y discovery + development using oncogenomics with Broad Institute 2013-09-10
Neurodyn–Galantos: galantamine, 201309 acquisition of all assets related to Memogain® formulation of galantamine by Neurodyn 2013-09-09
Analytik Jena–Endress+Hauser: investment, 201309 capital increase €24.4m incl Endress+Hauser with resulting direct + indirect 47.33% share for E+H 2013-09-04
Analytik Jena–SEVERAL: investment, 201309 capital increase €24.4m €23.4m net 1.95m new shares €12.5/share exlusively to existent shareholders 2013-09-04
Perora–High-Tech Gründerfonds: investment, 201309 seed financing round led by HTGF 2013-09-04
Boehringer–Diaxonhit: drug discovery services, 201309– supply service €na discovery of oncology drug targets using SpliceArray platform 2013-09-03
Leukocare–SEVERAL: investment, 201309 capital increase €3.4m incl conversion of €1m corporate bond from new + existing investors 2013-09-03
EpimiRNA project–Bicoll: drug discovery technology, 201309–201808 Bicoll is project partner using its Profiles technology for drug discovery 2013-09-01
Q-Bioanalytic–EU (govt): grant, 201309–201608 FP7 grant €670k as member of DIAGMAL project 2013-09-01
Evotec–BVF Partners: investment, 201308 capital increase €30m 11.8m new shares €2.55/share to Biotechnology Value Fund LP 2013-08-31
Genfit–Bicoll: drug discovery technology, 201308 collab existent using Bicoll’s Profiles technology for target identification 2013-08-29
Life Technologies–PIKA Weihenstephan: molecular food testing, 201308– distribution of PIKA’s Fast Orange Nutrient + PCR tests for brewing + beverages 2013-08-26
Omnilab (DE)–Serva Electrophoresis: electrophoresis, 201308– distribution of Serva products + reagents by Onmilab 2013-08-22
Helmholtz–NN: mass spectrometer, 201308 supply existent use of SIMS at HZDR in Dresden 2013-08-21
Helmholtz–NN: mass spectrometer, 201308 supply installation of €3.6m SIMS at GeoForschungsZentrum Potsdam 2013-08-21
Epigenomics–Yorkville Group: investment, 201308– standby equity line up to $5m convertible bonds to be purchased 2y by YA Global Master SPV on request 2013-08-19
Eppendorf–Manufactus: manufacturing software, 201308– supply use of eKanban System IKS by Eppendorf Liquid Handling GmbH 2013-08-16
PP Wealth–SEVERAL: investment, 201308– private placement up to €32.5m of Valeado GmbH & Co KG set up by Lead Discovery Center + PP Wealth GmbH 2013-08-16
CAP-CMV GmbH–SEVERAL: investment, 201308–201403 seed/startup financing rounds €1.7m by PVP + NRW.Bank + Creathor Venture + KfW + private investors 2013-08-12
Syngenta–Caprotec: CCMS technology, 201307– supply service €na profiling interactions of new active ingredients with proteome for Syngenta 2013-08-12
Bayer–Compugen: cancer immunotherapy, 201308– collab r+d + ww excl license $10m upfront + $530m milestones + royalties against 2 targets 2013-08-05
Danone–Eurofins: food analysis, 201308– supply food testing service at least €30m revenue over 5y by newly acquired CLF 2013-08-02
Danone–Eurofins: investment, 201308 acquisition of Central Laboratories Friedichsdorf (in-house Milupa lab) by Eurofins 2013-08-02
Exelonix–High-Tech Gründerfonds: investment, 201308 seed financing from HTGF 2013-08-02
Apeiron–Rentschler: biological contract manufacturing, 201308– production + supply of APN311 for clinical studies + market 2013-08-01
Axa–Klocke: investment, 201308–201311 acquisition €na of Animal Health div of Riemser Pharma GmbH + production facility in Riems by IDT Biologika 2013-08-01
CorTec–High-Tech Gründerfonds: investment, 201308 existent HTGF is investor in CorTec GmbH 2013-08-01
E-HOD project–EU (govt): grant, 201308– grant €1.15m over 3 years 2013-08-01
NovaPump–High-Tech Gründerfonds: investment, 201307 1st financing round with HTGF 2013-07-31
Capical–SEVERAL: investment, 201307 financing Series A from M-Invest + KfW 2013-07-30
Noxxon–College Group: public relations, 201307 service existent by College Hill Life Sciences 2013-07-24
CorTec–SEVERAL: investment, 201307 2nd financing round €3m incl new investors M-Invest + KfW 2013-07-23
JenaValve–SEVERAL: investment, 201307 financing round Series C $62.5m led by Gimv 2013-07-23
Poonawalla–Deutsche Stiftung Impfstoffforschung: tuberculosis vaccine, 201307– acquisition of rights to VPM1002 by Serum Institute of India from VPM 2013-07-23
Qiagen–Exosome Diagnostics: nucleic acid sample preparation, 201307– collab excl €na developm + commerc sample prep kits for NA from exosomes 2013-07-23
Bayer–Caprotec: CCMS technology, 201307– supply service €na profiling interactions of new active ingredients for 2nd target of Bayer CropScience 2013-07-22
Caprotec–College Group: public relations, 201307 service existent by College Hill Life Sciences 2013-07-22
OctreoPharm–Eckert & Ziegler: investment, 201307 acquisition of minority interest in OctreoPharm Sciences GmbH by Eckert & Ziegler Radiopharma GmbH 2013-07-22
CI3 Cluster–Abbott: personalised immunotherapy, 201307 collab existent Abbott GmbH & Co KG is cluster partner 2013-07-21
CI3 Cluster–AdiuTide Pharmaceuticals: personalised immunotherapy, 201307 collab existent AdiuTide Pharmaceuticals GmbH is cluster partner 2013-07-21
CI3 Cluster–Aesku Diagnostics: personalised immunotherapy, 201307 collab existent Aesku Diagnostics GmbH & Co KG is cluster partner 2013-07-21
CI3 Cluster–Ageneo: personalised immunotherapy, 201307 collab existent Ageneno Life Science Experts GmbH is cluster partner 2013-07-21
CI3 Cluster–AMP-Lab: personalised immunotherapy, 201307 collab existent AMP-Lab GmbH is cluster partner 2013-07-21
CI3 Cluster–Aspiras: personalised immunotherapy, 201307 collab existent Aspiras GbR is cluster partner 2013-07-21
CI3 Cluster–Avia: personalised immunotherapy, 201307 collab existent Avia Industrial Services GmbH is cluster partner 2013-07-21
CI3 Cluster–Baimos Technologies: personalised immunotherapy, 201307 collab existent Baimos Technologies GmbH is cluster partner 2013-07-21
CI3 Cluster–Baker & McKenzie: personalised immunotherapy, 201307 collab existent Baker McKenzie is cluster partner 2013-07-21
CI3 Cluster–Baxter: personalised immunotherapy, 201307 collab existent Baxter GmbH is cluster partner 2013-07-21
CI3 Cluster–BCNP Consultants: personalised immunotherapy, 201307 collab existent BCNP Consultants GmbH is cluster partner 2013-07-21
CI3 Cluster–BioKryo: personalised immunotherapy, 201307 collab existent BioKryo GmbH is cluster partner 2013-07-21
CI3 Cluster–BioNTech: personalised immunotherapy, 201307 collab existent BioNTech AG is cluster partner 2013-07-21
CI3 Cluster–BioNTech: personalised immunotherapy, 201307 collab existent Eufets GmbH is cluster partner 2013-07-21
next pagenext page 1 2 3 4 ... 61 62 63  next pagenext page



Advertisement

Banner EBD Group BIO Europe 2014 BEU Frankfurt November 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Erfolgreicher Nischenanbieter im LC/MS-Markt sucht Junior-Partner 600x60px

» top

Advertisements

Banner EBD Group BIO Europe 2013 BEU Frankfurt November 120x180px Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 120x240px Banner LSBC Central European Life Science Investment Conference 2014 120x180px The Events Group Pharm Connect Congress 2015 Budapest February 120x180px Banner C5 Communications Life Sciences IP Summit 2014 Amsterdam 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px